Pharmacological effect on C-reactivite protein level and its relation to the cardiovascular risk

Abstract

The plasma hs-CRP level modulates the statin effect. Patients with elevated hs-CRP levels benefif significantly from rosuvastatin therapy while no benefit from this therapy was observed in patients with low hs-CRP levels and chronic heart failure.

Keywords

• C-reactive protein
• hs-CRP levels
• statins
• rosuvastatin
• JUPITER trial
• CORONA trial